Impact of the 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in infants younger than 90 days in England and Wales

Clinical Infectious Diseases

Volumn 56, Issue 5, 2013, Pages 633-640

  Ladhani, Shamez N ^a   Andrews, Nick J ^a   Waight, Pauline ^a   Borrow, Ray ^a   Slack, Mary P E ^a   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

herd immunity; invasive pneumococcal disease; neonatal; outcome; vaccine impact

Indexed keywords

7 VALENT PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; FATALITY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; INFANCY; INFANT; INFANT MORTALITY; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEWBORN; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SEROTYPE; UNITED KINGDOM; VACCINATION;

EID: 84873685845     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis934     Document Type: Article

References (28)

1. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
2. Jit M. The risk of sequelae due to pneumococcal meningitis in highincome countries: a systematic review and meta-analysis. J Infect 2010; 61:114-24.
3. Trotter CL, Waight P, Andrews NJ, et al. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J Infect 2010; 60:200-8.
4. Department of Health. Planned changes to the routine Childhood Immunisation Programme. Gateway reference:6126. 2006. Available at: http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/ Dearcolleagueletters/DH-4128120. Accessed 10 October 2012.
5. Anonymous. Quarterly vaccination coverage statistics for children aged up to five years in the UK (COVER programme): April to June 2011. Health Protection Reports 2011; 5:6-10. Available at: http://www.hpa.org.uk/hpr/ archives/2011/hpr3811.pdf. Accessed 10 October 2012.
6. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11:760-8.
7. Department of Health. Changes to the childhood pneumococcal conjugate vaccine. Gateway reference:13414. 2010. Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH-111299. Accessed 10 October 2012.
8. Geelen SP, Gerards LJ, Fleer A. Pneumococcal septicemia in the newborn. A report on seven cases and a review of the literature. J Perinat Med 1990; 18:125-9.
9. Westh H, Skibsted L, Korner B. Streptococcus pneumoniae infections of the female genital tract and in the newborn child. Rev Infect Dis 1990; 12:416-22.
10. Gomez M, Alter S, Kumar ML, Murphy S, Rathore MH. Neonatal Streptococcus pneumoniae infection: case reports and review of the literature. Pediatr Infect Dis J 1999; 18:1014-8.
11. Bas AY, Demirel N, Aydin M, Zenciroglu A, Tonbul A, Tanir G. Pneumococcal meningitis in the newborn period in a prevaccination era: a 10-year experience at a tertiary intensive care unit. Turk J Pediatr 2011; 53:142-8.
12. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295:1668-74.
13. Sheppard CL, Harrison TG, Smith MD, George RC. Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples. J Med Microbiol 2011; 60:49-55.
14. Andrews JM. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009; 64:454-89.
15. Department of Health. Pneumococcal (chapter 25). In: Salisbury D, Ramsay M, Noakes K, eds. Immunisation against infectious disease: The Green Book. 2006 updated ed. Norwick: The Stationary Office; 2011; 295-313.
16. Flasche S, Slack M, Miller E. Long term trends introduce a potential bias when evaluating the impact of the pneumococcal conjugate vaccination programme in England and Wales. Euro Surveill 2011; 16:19868.
17. Hospital Episode Statistics (HES) Online. Maternity data. 2012. Available at: http://www.hesonline.nhs.uk/Ease/servlet/ContentServer? siteID=1937&categoryID=1804. Accessed 10 October 2012.
18. Jefferson T, Ferroni E, Curtale F, Giorgi RP, Borgia P. Streptococcus pneumoniae in Western Europe: serotype distribution and incidence in children less than 2 years old. Lancet Infect Dis 2006; 6:405-10.
19. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363:292-4.
20. Hoffman JA, Mason EO, Schutze GE, et al. Streptococcus pneumoniae infections in the neonate. Pediatrics 2003; 112:1095-1102.
21. Primhak RA, Tanner MS, Spencer RC. Pneumococcal infection in the newborn. Arch Dis Child 1993; 69:317-8.
22. Andrews N, Waight PA, Borrow R, et al. Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales. PLoS One 2011; 6: e28435.
23. Singh J, Dick J, Santosham M. Colonization of the female urogenital tract with Streptococcus pneumoniae and implications for neonatal disease. Pediatr Infect Dis J 2000; 19:260-2.
24. Beargie R, Lynd P, Tucker E, Duhring J. Perinatal infection and vaginal flora. Am J Obstet Gynecol 1975; 122:31-3.
25. Simpson JM, Patel JS, Ispahani P. Streptococcus pneumoniae invasive disease in the neonatal period: an increasing problem? Eur J Pediatr 1995; 154:563-6.
26. Deutscher M, Lewis M, Zell ER, Taylor TH Jr., Van BC, Schrag S. Incidence and severity of invasive Streptococcus pneumoniae, group A streptococcus, and group B streptococcus infections among pregnant and postpartum women. Clin Infect Dis 2011; 53:114-23.
27. Adriani KS, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in pregnancy: report of six cases and review of the literature. Clin Microbiol Infect 2012; 18:345-51.
28. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011; 29:9127-9131.